2m 2m 2m 2m 2m 2m 2m
XTL BIOPHARM SP ADR (XTLB)
NASDAQ
$2.60-$0.18 (-6.65%)
Price as of Aug 21, 2026 7:15 PM EDT- $6.8MMarket Cap
- -40.85%1-Year Change
- BiotechnologyIndustry
XTL BIOPHARM SP ADR (XTLB)
$2.60-$0.18 (-6.65%)
XTLB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.78 | ||
Change | +$0.02 (+0.66%) | ||
Open | $2.78 | ||
High | $2.78 | ||
Low | $2.78 | ||
Previous Close | $2.76 | ||
Volume | 520 | ||
30-Day Average Volume | 9,837 | ||
1-Week Change | -0.18% | ||
1-Month Change | -4.79% | ||
1-Year Change | -40.85% | ||
3-Year Change | -25.26% | ||
5-Year Change | -84.86% | ||
Fundamentals | |||
Shares Outstanding | 2.5M | ||
Total Assets | $166,000.00 | ||
Market Cap | $6.8M | ||
Enterprise Value | $6.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 03/25/2026 | ||
Earnings & Revenue